Circulating levels of norethindrone in women with a single silastic implant.

[1]  S. Hillier,et al.  Long-term contraception by steroid releasing implants. VI. Serum concentrations of norethindrone in women bearing a single silastic implant releasing norethindrone acetate. , 1977, Contraception.

[2]  E. Johansson,et al.  Plasma levels of d-norgestrel and ovarian function in women using intravaginal rings impregnated with dl-norgestrel for several cycles. , 1976, Contraception.

[3]  E. Johansson,et al.  Plasma levels of d-norgestrel, estradiol and progesterone during treatment with silastic implants containing d-norgestrel. , 1976, Contraception.

[4]  K. Laumas,et al.  Long-term contraception by steroid-releasing implants. II. A preliminary report on long-term contraception by a single silastic implant containing norethindrone acetate (ENTA) in women. , 1975, Contraception.

[5]  K. Nygren,et al.  Radioimmunoassay of norethindrone: peripheral plasma levels after oral administration to humans and rhesus monkeys. , 1974, Contraception.

[6]  S. Wardlaw,et al.  Gamma globulin protection of radioimmunoassay and competitive protein binding saturation analysis of steroids. , 1972, The Journal of clinical endocrinology and metabolism.

[7]  E. Coutinho,et al.  Longterm contraception by subcutaneous silasticR capsules containing megestrol acetate , 1970 .

[8]  S. Tejuja.  Use of subcutaneous Silastic capsules for long-term steroid contraception. , 1970, American journal of obstetrics and gynecology.

[9]  H. Croxatto,et al.  Fertility control in women with a progestogen released in microquantities from subcutaneous capsules. , 1969, American journal of obstetrics and gynecology.